1/29
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No study sessions yet.
Bioavailability
the rate and extent to which the active ingredient is absorbed and becomes available at the site of action
Bioequivalence (BE)
when pharmaceutical equivalents or pharmaceutical alternatives show no significant difference in rate and extent of absorption at the same molar dose
pharmaceutical equivalents
products with the same active ingredient, strength, dosage form, and route, meeting same UPS standar
what are pharmaceutical alternatives?
same therapeutic moiety but differ in salt/ester, dosage form, or strength; NOT interchangeable
what are therapeutic equivalents?
products that are pharmaceutically equivalent and bioequivalent, producing same clinical effect and safety
what is the difference between BA and BE?
QBA= how much drug reaches circulation (rate and extent)
BE=compares two products BA to determine equivalence
Difference between pharmaceutical equivalents and alternatives?
Equivalents→ same active ingredient, dosage form, route, strength
Alternatives → same active ingredient but different in salt/ester/dosage form/strength
why is bioavailability clinically important?
lower A → lower plasma concentration (Cmax) → reduced therapeutic effect and possible need for dose adjustment
factors that cause incomplete absorption
route of administration
physiological factors
pharmaceutical factors
Pharmaceutical factors that cause incomplete absorption
Excipients
Particle size
Polymorphism
Crystalline vs amorphous
Hydrate vs anhydrous form
Physiological factors affecting BA
Gastric emptying
Intestinal motility
GI pH
Food/fluid intake
Drug transporter
First-pass metabolism
What is first pass effect?
loss of drug during steps of absorption due to metabolism by the liver before reaching systemic circulation
What is absolute bioavailability (Fabs)?
fraction of dose reaching systemic circulation compared to IV
what is relative bioavailability (Frel)?
comparison of two non-IV products
does not give absolute BA
useful for generics
What does the FDA require for in vivo BA studies?
BA must be measured using plasma concentration-time profiles under a controlled study protocol
How do PK parameters affect the curve (Cp vs T)?
↑ absorption rate → ↑ Cmax,↓ Tmax
↓ absorption → ↓Cmax, ↑ Tmax
AUC changes only with changes in extent of absorption (F)
how does AUC relate to BA?
AUC reflects the extent of drug reaching systemic circulation; directly proportional to bioavailable dose
Which metrics measure rate of absorption?
Cmax and Tmax
Methods to calculate/determine AUC?
blood level equations
Trapezoidal rule (using plasma concentrations over time)
Can urinary excretion be used to estimate BA?
Yes. BA is proportional to the amount of unchanged drug excreted in urine
What are the limits of BA (AUC) calculation methods
blood equations require accurate PK modeling
trapezoidal rule requires complete sampling
Urinary methods are not valid if drug is heavily metabolized
When is AUC directly proportional to dose?
when bioavailability is independent of dose
What is the general BA/BE testing procedure?
12-24 healthy adults
overnight fasting
Administer the drug with water
collect urine/blood
analyze concentration
plot data
What is 2×2 crossover design?
subjects receive both products (test &reference), separated by a washout period of ≥ 5.5-8.5 half lives, to minimize variation
What is the FDA’s BE statistical requirement for BE ("80/125 rule")?
The 90% confidence interval for AUC and Cmax must fall within 80-125% of the reference
What happens if AUC, Cmax, or Tmax differ significantly?
The products are not bioequivalent. Statistical analysis required if results are close
What does "AA" FDA code mean?
products with no known bioequivalence problems; conventional dosage forms
What does BX mean?
insufficient data to determine BE; not considered therapeutically equivalent
What does "BC" mean?
Controlled release forms with known bioequivalence issues
What does "BE" mean?
Enteric coated tablets with unresolved BE issues